carvedilol has been researched along with Renal Insufficiency, Chronic in 8 studies
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol." | 3.91 | Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019) |
| "The utility of β-blockers in the treatment of hypertension has created much speculation as to their efficacy in patients with comorbid conditions, and there are concerns regarding their adverse metabolic effects." | 2.48 | Vasodilating versus first-generation β-blockers for cardiovascular protection. ( Fares, H; Lavie, CJ; Ventura, HO, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sessa, M | 1 |
| Mascolo, A | 1 |
| Rasmussen, DB | 1 |
| Kragholm, K | 1 |
| Jensen, MT | 1 |
| Sportiello, L | 1 |
| Rafaniello, C | 1 |
| Tari, GM | 1 |
| Pagliaro, C | 1 |
| Andersen, M | 1 |
| Rossi, F | 1 |
| Capuano, A | 1 |
| Maekawa, M | 1 |
| Takahashi, A | 1 |
| Miki, Y | 1 |
| Roberts, MA | 1 |
| Darssan, D | 1 |
| Badve, SV | 1 |
| Carroll, RP | 1 |
| Fahim, MA | 1 |
| Haluska, BA | 1 |
| Hawley, CM | 1 |
| Isbel, NM | 1 |
| Marshall, MR | 1 |
| Pascoe, EM | 1 |
| Pedagogos, E | 1 |
| Pilmore, HL | 1 |
| Snelling, P | 1 |
| Stanton, T | 1 |
| Tan, KS | 1 |
| Tonkin, AM | 1 |
| Vergara, LA | 1 |
| Ierino, FL | 1 |
| Assimon, MM | 1 |
| Brookhart, MA | 1 |
| Fine, JP | 1 |
| Heiss, G | 1 |
| Layton, JB | 1 |
| Flythe, JE | 1 |
| Hanauer Schaab, E | 1 |
| Lanchote, VL | 1 |
| Balthazar Nardotto, GH | 1 |
| Marques Pereira, MP | 1 |
| Dantas, M | 1 |
| Paiva, CE | 1 |
| Barbosa Coelho, E | 1 |
| Hahn, L | 1 |
| Hahn, M | 1 |
| Fares, H | 1 |
| Lavie, CJ | 1 |
| Ventura, HO | 1 |
| Yasuda, G | 1 |
| Yatsu, K | 1 |
| Yamamoto, Y | 1 |
| Hirawa, N | 1 |
1 review available for carvedilol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Vasodilating versus first-generation β-blockers for cardiovascular protection.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Benzopyrans; Blood Glucose; Blood | 2012 |
3 trials available for carvedilol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Biomarkers; Carbazoles; Carvedilol; Female; Heart Diseases | 2017 |
Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Carvedilol; Case-Control Studies; Cross-Over S | 2020 |
Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood | 2012 |
4 other studies available for carvedilol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol | 2019 |
Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diabetic Nephropathies; Female; Humans; Hypogly | 2017 |
A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Carvedilol; Cohort Studies; Female; Humans; Male; Meto | 2018 |
Carvedilol-induced hyperkalemia in a patient with chronic kidney disease.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Carbazoles; Carvedilol; Dose-Response Relati | 2015 |